Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Quantum-enhanced Perovskite crystal scintillators for Innovative X-ray photon-counting in medical imaging and other applications (QuPIX)

Project description

Sharper scans at lower doses of radiation

Photon-counting computed tomography (PCCT) can bring sharper images, require lower radiation doses and deliver colour X-ray scans that reveal tissue composition in unprecedented detail. However, PCCT is more expensive than conventional CT systems, making adoption in hospitals limited. The EIC-funded QuPIX project aims to develop an affordable, scalable photon-counting detector built on quantum-enhanced perovskite scintillators and micro-avalanche photon counters. By tackling challenges in light output, energy resolution and X-ray absorption, QuPIX will validate a new generation of detectors at laboratory scale. This will pave the way for commercial systems that could transform medical imaging and beyond.

Objective

"Photon-counting computed tomography (PCCT) heralds the next leap in (medical) X-ray imaging and delivers images with astonishingly high contrast, high spatial resolution, and low noise. Moreover, PCCT allows a reduction in X-ray dose compared to conventional CT. Uniquely, the spectral capabilities of PCCT (also called ""color"" CT) enable quantitative imaging functions, such as measuring tissue composition or the concentration of contrast agents. The widespread use of PCCT in hospitals is still hampered by high costs; PCCT scanners are 3 to 5 times more expensive than conventional CT systems. Moreover, current PCCT detector technology has limited accuracy in spectral imaging tasks. QuPIX will unlock the full clinical potential of X-ray photon counting, both in diagnosis and image-guided interventions, by delivering a new, affordable, and scalable X-ray photon counting detector based on quantum-enhanced perovskite scintillators (QuPS) and micro-avalanche photon counters (muAPC). QuPIX builds on recent scientific discoveries, while addressing major challenges related to fundamental QUPS characteristics such as light output, energy resolution, and X-ray stopping power. Moreover, a new light sensor is needed to optimally utilize the unique properties of QuPS. QuPIX will solve these challenges and validate the new detector technology at laboratory level, providing a solid foundation for the future commercial development of QuPIX-based imaging systems for the medical and other markets (e.g. security), with a combined volume of tens of billions of euros. The QuPIX consortium has all the expertise and facilities to achieve these objectives, following a multidisciplinary methodology that combines scientific investigation, dissemination, and exploitation. Ultimately, QuPIX will revolutionize medical imaging, make Europe the leader in PCCT detectors, improve the quality and affordability of healthcare, and allow patients to benefit from faster and more accurate diagnosis."

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-PATHFINDEROPEN

See all projects funded under this call

Coordinator

TECHNISCHE UNIVERSITEIT DELFT
Net EU contribution
€ 965 677,50
Total cost
€ 965 677,50

Participants (5)